Biologic Drugs With Established Pharmaceutical Class: Interleukin-17A Antagonist
✉ Email this page to a colleague
Biologic Drugs With Established Pharmaceutical Class: Interleukin-17A Antagonist
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Novartis Pharmaceuticals Corporation | COSENTYX | secukinumab | Injection | 125504 | 2015-01-21 | ⤷ Get Started Free | ⤷ Get Started Free |
| Eli Lilly And Company | TALTZ | ixekizumab | Injection | 125521 | 2016-03-22 | ⤷ Get Started Free | ⤷ Get Started Free |
| Novartis Pharmaceuticals Corporation | COSENTYX | secukinumab | Injection | 761349 | 2023-10-06 | ⤷ Get Started Free | ⤷ Get Started Free |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Patent Expiration |
